Among 41 patients with this rare and highly aggressive RCC subtype, the objective response rate (ORR) was 56% with the ...

And if you're looking for top dividend-paying companies to put your money in right now, let's consider two excellent ...

The Swiss government has met with senior executives from Roche (ROG: SIX) and Novartis (NOVN: VX) to discuss the outlook for ...

The overwhelming federal nature of this subject is apparent,” the lawsuit alleges. “States are not free to tinker with ...

A New Jersey pharmaceutical company filed a lawsuit in federal court last week challenging a new Maine law aimed to protect a ...

The two biggest weight-loss drugmakers have lost $252bn in value this year, as investor enthusiasm for obesity treatments ...

The executive order from President Donald Trump calls on the HHS' Office of the Assistant Secretary for Preparedness and ...

Switzerland’s economic growth slowed sharply in the second quarter as U.S. tariff frontrunning seen earlier in the year ...

Identifying specific biomarkers and clinical characteristics is crucial for predicting a patient's response to both existing and emerging treatments for chronic spontaneous urticaria, thereby moving ...

The $1.2 billion in-space manufacturing market is expected to grow and be worth more than $20 billion by 2033.

Researchers found significant variability in the dissolution profiles extended-release methylphenidate formulations across manufacturers.

On July 30, 2025, Baltimore hosted a pivotal gathering—the Trust‑Based Community Health Summit—at the Thurgood Marshall ...